CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	1 Months Ended	2 Months Ended	3 Months Ended	7 Months Ended	9 Months Ended
	Jul. 21, 2023	Sep. 30, 2023	Sep. 30, 2022	Jul. 21, 2023	Sep. 30, 2022
Operating expenses:
Selling, general and administrative	$ 1,055	$ 5,265	$ 2,436	$ 9,841	$ 8,171
Research and development	1,573	6,388	7,477	19,803	25,225
Change in fair value of contingent consideration		(75,939)
Total operating costs and expenses	2,628	(64,286)	9,913	29,644	33,396
(Loss) income from operations	(2,628)	64,286	(9,913)	(29,644)	(33,396)
Other (loss) income:
Change in fair value of convertible notes	(13,249)		(666)	(19,359)	15,261
Change in fair value of warrants		1,593
Change in fair value of embedded forward purchase agreements and derivative liabilities	(11,789)	(15,776)		(11,789)
Other income, net	5	186	141	114	142
Total other (loss) income, net	(25,033)	(13,997)	(525)	(31,034)	15,403
(Loss) income before taxes	(27,661)	50,289	(10,438)	(60,678)	(17,993)
Income taxes	0	0	0	0	0
(Loss) income and comprehensive (loss) income	$ (27,661)	$ 50,289	$ (10,438)	$ (60,678)	$ (17,993)
Basic net (loss) income per share (in dollars per share)	$ (0.20)	$ 1.35	$ (0.08)	$ (0.44)	$ (0.13)
Diluted net (loss) income per share (in dollars per share)	$ (0.20)	$ 1.35	$ (0.08)	$ (0.44)	$ (0.13)
Weighted average shares of common stock outstanding used to compute basic net loss per share	138,848,177	37,159,600	138,848,177	138,848,177	138,848,177
Weighted average shares of common stock outstanding used to compute diluted net loss per share	138,848,177	37,159,600	138,848,177	138,848,177	138,848,177